NEWSROOM

ALL Press Release Awards Media Center

Press Release

2024. 07. 08

Innorna Announces U.S. FDA Rare Pediatric Disease Designation Granted to IN022 for the Treatment of Homocystinuria

Press Release

2024. 06. 05

Innorna receives IND clearance for its first-in-class bivalent RSV mRNA vaccine in China

Awards

2024. 04. 07

Innorna CEO Dr. Linxian Li Named as a 2024 In Vivo Rising Leader

Press Release

2024. 04. 17

Innorna's broad-spectrum SARS-CoV-2 mRNA vaccine receives Phase II clinical trial approval from FDA

2024. 02. 01

Innorna appointed Dr. Zhu Zhiqing as the Chief Technology Officer

Awards

2024. 01. 22

2023 Venture50 Announced: Innorna Ranked on Two Lists

Press Release

2024. 01. 12

Innorna Receives IND Clearance by FDA Enabling Phase I Initiation for Bivalent Respiratory Syncytial Virus mRNA Vaccine

Press Release

2023. 09. 23

Innorna Receives IND Clearance by FDA Enabling Phase I Initiation for Herpes Zoster mRNA Vaccine

Awards

2023. 09. 19

Innorna Honored To Be Ranked On The 2023 List of Fortune China's Most Socially Influential Startups

Awards

2023. 09. 01

Innorna Was Listed on The "2023 Top 100 Startups" by China Entrepreneur Magazine

Media Center

2022. 09. 08

ZFSW: Carrying Out Technical Cooperation with Innorna, Focusing on Specific mRNA R&D Projects

Press Release

2022. 07. 07

Innorna and BeiGene Launch Strategic Collaboration to Develop Innovative mRNA Products